Skip to main content
Figure 2 | World Journal of Surgical Oncology

Figure 2

From: Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma

Figure 2

The overall survival grouped by NLR and PLR. Patients with NLR ≥3.5 had significantly poorer overall survival compared to NLR <3.5 (35.4% versus 57.7%, P < 0.001) (A). Patients with PLR ≥150 also had significantly poorer overall survival compared to patients with PLR <150 (32.7% versus 63.5%, P < 0.001) (B). NLR, neutrophil lymphocyte ratio; PLR, platelet lymphocyte ratio.

Back to article page